Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children

NCT01091246 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT01091246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children
Lead sponsor
MedImmune LLC
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2010
Enrollment
2,312 (actual)
Sites
110

Conditions

As the registry lists them; a condition with its own page is linked.

healthy or stable chronic illness